Nosocomial Infections in Hospitalised Haematological Patients: A Retrospective Observational Record‐Based Study
8 affiliations
- 1Nursing Department Catalan Institute of Oncology – Germans Trias i Pujol Hospital Badalona Spain
- 2NURECARE Research Group Germans Trias i Pujol Research Institute and Hospital (IGTP) Badalona, Barcelona Spain
- 3Department Research Catalan Institute of Oncology – Germans Trias i Pujol Hospital Badalona Spain
- 4Nursing Department Autonomous University of Barcelona Barcelona Spain
- 5GRIN Group, IDIBELL Institute of Biomedical Research, University of Barcelona, Nursing School, Campus of Health Sciences L'Hospitalet de Llobregat, Barcelona Spain
- 6Programa VINCat, Catalan Health Service, Government of Catalonia Catalonia Spain
- 7Network Center for Biomedical Research on Infectious Diseases (CIBERINFEC) Carlos III Health Institute Madrid Spain
- 8Department of Public Health, Mental Health, and Maternal and Child Nursing, Faculty of Nursing University of Barcelona Barcelona Spain
Abstract
Aim: To estimate the prevalence of nosocomial infections in haematological patients hospitalised between 2020 and 2022, identify associated risk factors, and describe antibiotic use before and during hospitalisation.
Background: Studies integrating clinical, environmental, microbiological and pharmacological data in this population remain limited.
Design and Method: Retrospective observational record‐based study of haematology admissions from 2020 to 2022. Analyses distinguished patient, admission, clinical‐sample and microorganism‐isolate levels. Generalised estimating equations (GEE) accounted for repeated samples within patients and adjusted for clinically relevant covariates.
Results: Among 645 hospitalised haematological patients, 225 (34.9%) had at least one eligible positive microbiological sample. Of the total source population, 206 (31.9%) had at least one microbiologically documented infection meeting the study criteria during 2020–2022 and 60 (9.3%) had at least one colonisation episode, with 41 patients experiencing both. The 225 included patients contributed 285 admissions, 475 positive clinical samples and 572 microorganism isolates. In adjusted GEE models, the number of antibiotics received during the previous 90 days was associated with relapse (adjusted odds ratio [aOR] 1.23 per additional antibiotic, 95% CI 1.11–1.36; p < 0.001) and colonisation (aOR 1.14, 95% CI 1.04–1.25; p = 0.007); shared‐room exposure was associated with colonisation (aOR 3.58, 95% CI 1.79–7.15; p < 0.001), and cumulative device‐days with sample‐level co‐infection (aOR 1.10 per 10 device‐days, 95% CI 1.02–1.19; p = 0.016).
Conclusions: Prior antibiotic burden, shared‐room exposure and cumulative device‐days were associated with selected infection‐related outcomes. Causal inference is limited by the observational single‐centre design.
Relevance to Clinical Practice: Nursing priorities include daily assessment of device necessity, standardised catheter maintenance, hand hygiene, infection surveillance, patient education, and multidisciplinary antimicrobial stewardship.
Patient or Public Contribution: None. The study used routinely collected retrospective clinical data.
Related
- The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study
- Factors Associated With Candidemia in Hospitalised Patients in Mumbai, India: A Single Centre Retrospective Observational Study.
- Surveillance of bacterial and fungal infections in hospitalised COVID-19 patients: an ISARIC/WHO CCP-UK and UKHSA linkage study
- Determinants of extended inpatient care in odontogenic cervicofacial infections: a retrospective observational study.
- Limiting collateral damage: Nosocomial infections in patients with temporary mechanical circulatory support.
BibTeX
@article{cabrerajaime2026nosocomial,
title = {{Nosocomial Infections in Hospitalised Haematological Patients: A Retrospective Observational Record‐Based Study}},
author = {Laura Cabrera‐Jaime and Sandra Cabrera‐Jaime and Maria Feijoo‐Cid and Enric Limón},
journal = {Nursing Open},
year = {2026},
month = nov,
doi = {10.1002/nop2.70966},
url = {https://doi.org/10.1002/nop2.70966},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Nosocomial Infections in Hospitalised Haematological Patients: A Retrospective Observational Record‐Based Study
AU - Laura Cabrera‐Jaime
AU - Sandra Cabrera‐Jaime
AU - Maria Feijoo‐Cid
AU - Enric Limón
PY - 2026
DA - 2026/11/05
JO - Nursing Open
DO - 10.1002/nop2.70966
UR - https://doi.org/10.1002/nop2.70966
AB - Aim: To estimate the prevalence of nosocomial infections in haematological patients hospitalised between 2020 and 2022, identify associated risk factors, and describe antibiotic use before and during hospitalisation. Background: Studies integrating clinical, environmental, microbiological and pharmacological data in this population remain limited. Design and Method: Retrospective observational record‐based study of haematology admissions from 2020 to 2022. Analyses distinguished patient, admission, clinical‐sample and microorganism‐isolate levels. Generalised estimating equations (GEE) accounted for repeated samples within patients and adjusted for clinically relevant covariates. Results: Among 645 hospitalised haematological patients, 225 (34.9%) had at least one eligible positive microbiological sample. Of the total source population, 206 (31.9%) had at least one microbiologically documented infection meeting the study criteria during 2020–2022 and 60 (9.3%) had at least one colonisation episode, with 41 patients experiencing both. The 225 included patients contributed 285 admissions, 475 positive clinical samples and 572 microorganism isolates. In adjusted GEE models, the number of antibiotics received during the previous 90 days was associated with relapse (adjusted odds ratio [aOR] 1.23 per additional antibiotic, 95% CI 1.11–1.36; p < 0.001) and colonisation (aOR 1.14, 95% CI 1.04–1.25; p = 0.007); shared‐room exposure was associated with colonisation (aOR 3.58, 95% CI 1.79–7.15; p < 0.001), and cumulative device‐days with sample‐level co‐infection (aOR 1.10 per 10 device‐days, 95% CI 1.02–1.19; p = 0.016). Conclusions: Prior antibiotic burden, shared‐room exposure and cumulative device‐days were associated with selected infection‐related outcomes. Causal inference is limited by the observational single‐centre design. Relevance to Clinical Practice: Nursing priorities include daily assessment of device necessity, standardised catheter maintenance, hand hygiene, infection surveillance, patient education, and multidisciplinary antimicrobial stewardship. Patient or Public Contribution: None. The study used routinely collected retrospective clinical data.
SN - 2054-1058
ER -